Navigation Links
Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
Date:6/29/2009

SHANGHAI, June 29 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr. Tong Xu has been appointed Vice President of Process Chemistry Services.

Prior to joining Sundia, Dr. Xu worked at La Jolla Pharmaceutical Company, an R&D based biotech company in San Diego, USA for 12 years. At La Jolla Pharmaceutical Company, Dr. Xu rose through the ranks from Research Scientist, to Manager, Senior Manager, and Associate Director of Process Development. Through this career path, he accumulated extensive experience in developing and managing process chemistry programs. His accomplishments include directing process development effort of Riquent(R) at clinical phase III and pre-commercialization stage.

"I am very pleased to welcome Dr. Xu to join Sundia. He is not only an outstanding scientist and research fellow, but also an experienced business manager," said Dr. Xiaochuan Wang, Chairman and CEO of Sundia. "Dr. Xu led the effort in his previous employment to search, select, negotiate and qualify CRO service providers in GLP and cGMP production of raw materials, starting materials, and API intermediates. This experience is very valuable for his new role to lead process chemistry CRO services at Sundia."

Dr. Xu received his bachelor's degree in Chemistry from Nankai University, and his Ph.D. degree in Organic Chemistry from the University of Michigan in USA. He also obtained an MBA with focus on finance and entrepreneurship from the Anderson School of Management at UCLA in USA.

About Sundia: Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China, to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from early hit screening, biological service, lead optimization, DMPK, candidate preclinical development, formulation development, API manufacture, and regulatory submission. For more information, please visit http://www.sundia.com .


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
2. Sundias Animal Facility Passed Client and Government Inspection
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
5. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
6. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
7. Novavax Appoints Stanley Erck to Board of Directors
8. Qforma Appoints Four Executives in Sales and Field Operations
9. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
10. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
11. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
Breaking Biology News(10 mins):